NEW YORK (GenomeWeb) – Streck has inked a distribution agreement in Kuwait with Innovative Medical Solutions for its full portfolio of controls, cell stabilization, and molecular products.
Streck's cell stabilization products include Cyto-Chex BCT, a blood collection tube for the preservation of whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCT, a direct-draw blood collection tube that stabilizes nucleated blood cells and prevents the release of genomic DNA; Cell-Free RNA BCT, a blood collection tube with a preservative that stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage; and Cell-Free DNA Urine Preserve, a liquid reagent that stabilizes cell-free DNA in urine.
Streck's molecular products include its ARM-D Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the not-yet-launched rapid real-time PCR instrument Zulu RT. The firm's core product portfolio includes control products that test the performance and limits of instruments and reagents.
Innovative Medical Solutions is a specialty healthcare organization that serves as an exclusive distribution agent for multinational pharmaceutical and medical equipment manufacturers.
Streck, based in Omaha, Nebraska, has inked distribution deals in a number of regions and countries in recent months, including Indonesia, the Philippines, Canada, Slovakia, the Nordic countries, New Zealand, Singapore, Malaysia, Austria, Switzerland, and China.